Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Secures $4.56M in Highly Dilutive "Death Spiral" Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$3.24
Mkt Cap
$3.842M
52W Low
$3.03
52W High
$398.86
52W Position info
6.9% above low
Off High info
99% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ELAB is trading near its 52-week low of $3.03 (6.9% above the low).

Summary

PMGC Holdings Inc. has entered into a Secured Pre-Paid Purchase agreement to raise $4.56 million, a sum exceeding its current market capitalization, under terms highly unfavorable to existing shareholders.


Key Events · Financing and Capital Events · ELAB

  • Secured Pre-Paid Purchase

    The company secured $4.56 million in net proceeds through a "Secured Pre-Paid Purchase #3" agreement with Streeterville Capital, LLC.

  • Extreme Dilution Potential

    The capital raised ($4.56M) significantly exceeds the company's current market capitalization, indicating massive future dilution for existing shareholders.

  • Unfavorable Conversion Terms

    The investor can convert the principal into common stock at 88% of the lowest 10-day VWAP, a mechanism that typically exerts downward pressure on the stock price.

  • Punitive Prepayment and Default Clauses

    The company faces a 120% prepayment penalty and an automatic 15% increase in outstanding balance plus 18% interest upon default, making it difficult to exit the agreement.


Analysis · ELAB · Life Sciences

This financing agreement, often termed a "death spiral" due to its structure, allows the investor to convert debt into common stock at a significant discount (88% of the lowest 10-day VWAP). This mechanism creates a strong incentive for the investor to drive down the stock price, leading to substantial dilution for current shareholders. The company's need to raise capital in an amount greater than its entire market value, coupled with punitive prepayment penalties and default terms, signals severe financial distress and poses a significant risk to the company's stock value.

At the time of this filing, ELAB was trading at $3.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.8M. The 52-week trading range was $3.03 to $398.86. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Jul 07, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.08 info
Change: -$0.120 (-10%) info
Market Cap: $5.089M info
ELAB
Jul 06, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $1.08 info
Change: -$0.2487 (-19%) info
Market Cap: $5.089M info
ELAB
Jul 01, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $1.08 info
Change: -$0.490 (-31%) info
Market Cap: $5.089M info
ELAB
Jul 01, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $1.08 info
Change: -$0.200 (-16%) info
Market Cap: $5.089M info
ELAB
Jun 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $1.08 info
Change: -$0.400 (-27%) info
Market Cap: $5.089M info
ELAB
Jun 08, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $1.08 info
Change: -$0.480 (-31%) info
Market Cap: $5.089M info
ELAB
Jun 08, 2026, 7:31 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.79
Real-time Price: $1.08 info
Change: -$0.710 (-40%) info
Market Cap: $5.089M info
ELAB
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $1.08 info
Change: -$0.440 (-29%) info
Market Cap: $5.089M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.08 info
Change: -$0.730 (-40%) info
Market Cap: $5.089M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.08 info
Change: -$0.730 (-40%) info
Market Cap: $5.089M info